References
- Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, Panchalingam S, Wu Y, Sow SO, Sur D, Breiman RF, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet. 2013;382(9888):1–8. doi:https://doi.org/10.1016/S0140-6736(13)60844-2.
- Platts-Mills JA, Liu J, Rogawski ET, Kabir F, Lertsethtakarn P, Siguas M, Khan SS, Praharaj I, Murei A, Nshama R, et al. Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study. Lancet Glob Health. 2018;6(12):e1309–e18. doi:https://doi.org/10.1016/S2214-109X(18)30349-8.
- Kasumba IN, Pulford CV, Perez-Sepulveda BM, Sen S, Sayed N, Permala-Booth J, Livio S, Heavens D, Low R, Hall N, et al. Characteristics of Salmonella recovered from stools of children enrolled in the global enteric multicenter study. Clin Infect Dis. 2021. doi:https://doi.org/10.1093/cid/ciab051.
- Pulford CV, Perez-Sepulveda BM, Canals R, Bevington JA, Bengtsson RJ, Wenner N, Rodwell EV, Kumwenda B, Zhu X, Bennett RJ, et al. Stepwise evolution of Salmonella Typhimurium ST313 causing bloodstream infection in Africa. Nat Microbiol. 2021;6(3):327–38. doi:https://doi.org/10.1038/s41564-020-00836-1.
- Brandtzaeg P. Mucosal immunity: integration between mother and the breast-fed infant. Vaccine. 2003;21:3382–88. doi:https://doi.org/10.1016/S0264-410X(03)00338-4.
- Hennet T, Borsig L. Breastfed at Tiffany’s. Trends Biochem Sci. 2016;41:508–18. doi:https://doi.org/10.1016/j.tibs.2016.02.008.
- Labbok MH, Clark D, Goldman AS. Breastfeeding: maintaining an irreplaceable immunological resource. Nat Rev Immunol. 2004;4:565–72. doi:https://doi.org/10.1038/nri1393.
- Ruiz L, Espinosa-Martos I, García-Carral C, Manzano S, McGuire MK, Meehan CL, McGuire MA, Williams JE, Foster J, Sellen DW, et al. What’s Normal? Immune Profiling of Human Milk from Healthy Women Living in Different Geographical and Socioeconomic Settings. Front Immunol. 2017;8. doi:https://doi.org/10.3389/fimmu.2017.00696.
- Brandtzaeg P. The mucosal immune system and its integration with the mammary glands. J Pediatr. 2010;156(2):S8–15. doi:https://doi.org/10.1016/j.jpeds.2009.11.014.
- McGuire MK, Randall AZ, Seppo AE, Jarvinen KM, Meehan CL, Gindola D, Williams JE, Sellen DW, Kamau-Mbuthia EW, Kamundia EW, et al. Multipathogen analysis of IgA and IgG antigen specificity for selected pathogens in milk produced by women from diverse geographical regions: the INSPIRE study. Front Immunol. 2020;11:614372. doi:https://doi.org/10.3389/fimmu.2020.614372.
- Gopalakrishna KP, Hand TW. Influence of maternal milk on the neonatal intestinal microbiome. Nutrients. 2020;12(3):823. doi:https://doi.org/10.3390/nu12030823.
- Roux ME, McWilliams M, Phillips-Quagliata JM, Weisz-Carrington P, Lamm ME. Origin of IgA-secreting plasma cells in the mammary gland. J Exp Med. 1977;146:1311–22. doi:https://doi.org/10.1084/jem.146.5.1311.
- Wilson E, Butcher EC. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J Exp Med. 2004;200:805–09. doi:https://doi.org/10.1084/jem.20041069.
- Kirkwood CD, Ma LF, Carey ME, Steele AD. The rotavirus vaccine development pipeline. Vaccine. 2019;37:7328–35. doi:https://doi.org/10.1016/j.vaccine.2017.03.076.
- Amour C, Gratz J, Mduma E, Svensen E, Rogawski ET, McGrath M, Seidman, JC, McCormick, BJ, Shrestha, S, Samie, A, Mahfuz, M, Qureshi, S, Hotwani, A, Babji, S, Trigoso, DR, Lima, AA, Bodhidatta, L, Bessong, P, Ahmed, T, Shakoor, S, Kang, G, Kosek, M, Guerrant, RL, Lang, D, Gottlieb, M, Houpt, ER, Platts-Mills, JA. Epidemiology and impact of campylobacter infection in children in 8 low-resource settings: results from the MAL-ED study. Clin Infect Dis. 2016;63:1171–79.
- Platts-Mills JA, Kosek M. Update on the burden of Campylobacter in developing countries. Curr Opin Infect Dis. 2014;27:444–50. doi:https://doi.org/10.1097/QCO.0000000000000091.
- Riddle MS, Chen WH, Kirkwood CD, MacLennan CA. Update on vaccines for enteric pathogens. Clin Microbiol Infect. 2018;24:1039–45. doi:https://doi.org/10.1016/j.cmi.2018.06.023.
- Walker R, Kaminski RW, Porter C, Choy RKM, White JA, Fleckenstein JM, Cassels F, Bourgeois L. Vaccines for protecting infants from bacterial causes of diarrheal disease. Microorganisms. 2021;9. doi:https://doi.org/10.3390/microorganisms9071382.
- Virdi V, Palaci J, Laukens B, Ryckaert S, Cox E, Vanderbeke E, Depicker A, Callewaert N. Yeast-secreted, dried and food-admixed monomeric IgA prevents gastrointestinal infection in a piglet model. Nat Biotechnol. 2019;37:527–30. doi:https://doi.org/10.1038/s41587-019-0070-x.
- Kumar N, Arthur CP, Ciferri C, Matsumoto ML. Structure of the secretory immunoglobulin A core. Science. 2020;367(6481):1008–14. doi:https://doi.org/10.1126/science.aaz5807.
- Kumar Bharathkar S, Parker BW, Malyutin AG, Haloi N, Huey-Tubman KE, Tajkhorshid E, Stadtmueller BM. The structures of Secretory and dimeric Immunoglobulin A. Elife. 2020;9. doi:https://doi.org/10.7554/eLife.56098.
- Stadtmueller BM, Huey-Tubman KE, Lopez CJ, Yang Z, Hubbell WL, Bjorkman PJ. The structure and dynamics of secretory component and its interactions with polymeric immunoglobulins. Elife. 2016;5. doi:https://doi.org/10.7554/eLife.10640.
- de Sousa-Pereira P, Woof JM. IgA: structure, function, and developability. Antibodies (Basel). 2019;8(4):57. doi:https://doi.org/10.3390/antib8040057.
- Brandtzaeg P, Johansen FE. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev. 2005;206:32–63. doi:https://doi.org/10.1111/j.0105-2896.2005.00283.x.
- Stokes CR, Soothill JF, Turner MW. Immune exclusion is a function of IgA. Nature. 1975;255:745–46. doi:https://doi.org/10.1038/255745a0.
- Mantis NJ, Rol N, Corthesy B. Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011;4:603–11. doi:https://doi.org/10.1038/mi.2011.41.
- Binsker U, Lees JA, Hammond AJ, Weiser JN. Immune exclusion by naturally acquired secretory IgA against pneumococcal pilus-1. J Clin Invest. 2020;130:927–41. doi:https://doi.org/10.1172/JCI132005.
- Forbes SJ, Bumpus T, McCarthy EA, Corthesy B, Mantis NJ. Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA. mBio. 2011;2:e00042–11. doi:https://doi.org/10.1128/mBio.00042-11.
- Moor K, Diard M, Sellin ME, Felmy B, Wotzka SY, Toska A, Bakkeren E, Arnoldini M, Bansept F, Co AD. High-avidity IgA protects the intestine by enchaining growing bacteria. Nature. 2017;544:498–502. doi:https://doi.org/10.1038/nature22058.
- Ding M, Yang B, Ross RP, Stanton C, Zhao J, Zhang H, Chen W. Crosstalk between sIgA-Coated Bacteria in Infant Gut and Early-Life Health. Trends Microbiol. 2021;29:725–35. doi:https://doi.org/10.1016/j.tim.2021.01.012.
- Catanzaro JR, Strauss JD, Bielecka A, Porto AF, Lobo FM, Urban A, Schofield WB, Palm NW. IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM. Sci Rep. 2019;9(1):13574. doi:https://doi.org/10.1038/s41598-019-49923-2.
- Yang C, Chen-Liaw A, Moran TM, Cerutti A, Faith JJ Immunoglobulin a antibody composition is sculpted to bind the self gut microbiome. bioRxiv 2020:2020.11.30.405332.
- Schnee AE, Petri WA Jr. Campylobacter jejuni and associated immune mechanisms: short-term effects and long-term implications for infants in low-income countries. Curr Opin Infect Dis. 2017;30(3):322–28. doi:https://doi.org/10.1097/QCO.0000000000000364.
- Kirkpatrick BD, Tribble DR. Update on human Campylobacter jejuni infections. Curr Opin Gastroenterol. 2011;27(1):1–7. doi:https://doi.org/10.1097/MOG.0b013e3283413763.
- Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C, Operario DJ, Uddin J, Ahmed S, Alonso PL. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet. 2016;388(10051):1291–301. doi:https://doi.org/10.1016/S0140-6736(16)31529-X.
- Tribble DR, Baqar S, Scott DA, Oplinger ML, Trespalacios F, Rollins D, Walker RI, Clements JD, Walz S, Gibbs P. Assessment of the duration of protection in campylobacter jejuni experimental infection in humans. Infect Immun. 2010;78(4):1750–59. doi:https://doi.org/10.1128/IAI.01021-09.
- Ruiz-Palacios GM, Calva JJ, Pickering LK, Lopez-Vidal Y, Volkow P, Pezzarossi H, West MS. Protection of breast-fed infants against Campylobacter diarrhea by antibodies in human milk. J Pediatr. 1990;116(5):707–13. doi:https://doi.org/10.1016/S0022-3476(05)82652-6.
- Bacon DJ, Szymanski CM, Burr DH, Silver RP, Alm RA, Guerry P. A phase-variable capsule is involved in virulence of Campylobacter jejuni 81-176. Mol Microbiol. 2001;40(3):769–77. doi:https://doi.org/10.1046/j.1365-2958.2001.02431.x.
- Hickey TE, Majam G, Guerry P. Intracellular survival of campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin. Infect Immun. 2005;73(8):5194–97. doi:https://doi.org/10.1128/IAI.73.8.5194-5197.2005.
- Barrero-Tobon AM, Hendrixson DR. Flagellar biosynthesis exerts temporal regulation of secretion of specific Campylobacter jejuni colonization and virulence determinants. Mol Microbiol. 2014;93:957–74. doi:https://doi.org/10.1111/mmi.12711.
- Guerry P. Campylobacter flagella: not just for motility. Trends Microbiol. 2007;15:456–61. doi:https://doi.org/10.1016/j.tim.2007.09.006.
- Lertsethtakarn P, Ottemann KM, Hendrixson DR. Motility and chemotaxis in Campylobacter and Helicobacter. Annu Rev Microbiol. 2011;65:389–410. doi:https://doi.org/10.1146/annurev-micro-090110-102908.
- Tegtmeyer N, Sharafutdinov I, Harrer A, Soltan Esmaeili D, Linz B, Backert S. Campylobacter Virulence Factors and Molecular Host-Pathogen Interactions. Curr Top Microbiol Immunol. 2021;431:169–202.
- Yao R, Burr DH, Doig P, Trust TJ, Niu H, Guerry P. Isolation of motile and non-motile insertional mutants of Campylobacter jejuni: the role of motility in adherence and invasion of eukaryotic cells. Mol Microbiol. 1994;14:883–93. doi:https://doi.org/10.1111/j.1365-2958.1994.tb01324.x.
- Takata T, Fujimoto S, Amako K. Isolation of nonchemotactic mutants of Campylobacter jejuni and their colonization of the mouse intestinal tract. Infect Immun. 1992;60:3596–600. doi:https://doi.org/10.1128/iai.60.9.3596-3600.1992.
- Pavlovskis OR, Rollins DM, Haberberger RL Jr., Green AE, Habash L, Strocko S, Walker, RI. Significance of flagella in colonization resistance of rabbits immunized with Campylobacter spp. Infect Immun. 1991;59:2259–64. doi:https://doi.org/10.1128/iai.59.7.2259-2264.1991.
- Black RE, Levine MM, Clements ML, Hughes TP, Blaser MJ. Experimental Campylobacter jejuni infection in humans. J Infect Dis. 1988;157:472–79. doi:https://doi.org/10.1093/infdis/157.3.472.
- Thibault P, Logan SM, Kelly JF, Brisson JR, Ewing CP, Trust TJ, Guerry, P. Identification of the carbohydrate moieties and glycosylation motifs in Campylobacter jejuni flagellin. J Biol Chem. 2001;276:34862–70. doi:https://doi.org/10.1074/jbc.M104529200.
- Chintoan-Uta C, Cassady-Cain RL, Stevens MP. Evaluation of flagellum-related proteins FliD and FspA as subunit vaccines against Campylobacter jejuni colonisation in chickens. Vaccine. 2016;34:1739–43. doi:https://doi.org/10.1016/j.vaccine.2016.02.052.
- Perruzza L, Jaconi S, Lombardo G, Pinna D, Strati F, Morone D, Seehusen F, Hu Y, Bajoria S, Xiong J, Kumru OS, Joshi SB, Volkin DB, Piantanida R, Benigni F, Grassi F, Corti D, Pizzuto MS. Prophylactic activity of orally administered FliD-Reactive monoclonal siga against campylobacter infection. Front Immunol. 2020;11:1011. doi:https://doi.org/10.3389/fimmu.2020.01011.
- Guerrant RL, DeBoer MD, Moore SR, Scharf RJ, Lima AA. The impoverished gut–a triple burden of diarrhoea, stunting and chronic disease. Nat Rev Gastroenterol Hepatol. 2013;10:220–29. doi:https://doi.org/10.1038/nrgastro.2012.239.
- Fleckenstein JM, Kuhlmann FM. Enterotoxigenic Escherichia coli infections. Curr Infect Dis Rep. 2019;21:9. doi:https://doi.org/10.1007/s11908-019-0665-x.
- Riaz S, Steinsland H, Hanevik K. Human mucosal IgA immune responses against enterotoxigenic Escherichia coli. Pathogens. 2020;9(9):714. doi:https://doi.org/10.3390/pathogens9090714.
- Giuntini S, Stoppato M, Sedic M, Ejemel M, Pondish JR, Wisheart D, Schiller ZA, Thomas WD Jr, Barry EM, Cavacini LA, Klempner MS, Wang Y. Identification and characterization of human monoclonal antibodies for immunoprophylaxis against enterotoxigenic Escherichia coli infection. Infect Immun. 2018;86(8):e00355-18. doi: https://doi.org/10.1128/IAI.00355-18.
- Hu Y, Kumru OS, Xiong J, Antunez LR, Hickey J, Wang Y, Cavacini L, Klempner M, Joshi SB, Volkin DB. Preformulation characterization and stability assessments of secretory IgA monoclonal antibodies as potential candidates for passive immunization by oral administration. J Pharm Sci. 2020;109(1):407–21. doi:https://doi.org/10.1016/j.xphs.2019.07.018.
- Stoppato M, Gaspar C, Regeimbal J, Nunez RG, Giuntini S, Schiller ZA, Gawron MA, Pondish JR, Martin JC, Schneider MI, et al. Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model. Vaccine. 2020;38(10):2333–39. doi:https://doi.org/10.1016/j.vaccine.2020.01.064.
- Wallace AL, Schneider MI, Toomey JR, Schneider RM, Klempner MS, Wang Y, Cavacini LA. IgA as a potential candidate for enteric monoclonal antibody therapeutics with improved gastrointestinal stability. Vaccine. 2020;38:7490–97. doi:https://doi.org/10.1016/j.vaccine.2020.09.070.
- Teh AY, Cavacini L, Hu Y, Kumru OS, Xiong J, Bolick DT, Joshi SB, Grünwald-Gruber C, Altmann F, Klempner M. Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants. Gut Microbes. 2021;13(1):1–14. doi:https://doi.org/10.1080/19490976.2020.1859813.
- Darsley MJ, Chakraborty S, DeNearing B, Sack DA, Feller A, Buchwaldt C, Bourgeois AL, Walker R, Harro CD. The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease. Clin Vaccine Immunol. 2012;19(12):1921–31. doi:https://doi.org/10.1128/CVI.00364-12.
- Kariuki S, Mbae C, Van Puyvelde S, Onsare R, Kavai S, Wairimu C, Ngetich R, Clemens J, Dougan G. High relatedness of invasive multi-drug resistant non-typhoidal Salmonella genotypes among patients and asymptomatic carriers in endemic informal settlements in Kenya. PLoS Negl Trop Dis. 2020;14(8):e0008440. doi:https://doi.org/10.1371/journal.pntd.0008440.
- Rivera-Chavez F, Baumler AJ. The pyromaniac inside you: Salmonella metabolism in the host gut. Annu Rev Microbiol. 2015;69:31–48. doi:https://doi.org/10.1146/annurev-micro-091014-104108.
- Carter PB, Collins FM. The route of enteric infection in normal mice. J Exp Med. 1974;139:1189–203. doi:https://doi.org/10.1084/jem.139.5.1189.
- Rivera-Chavez F, Lopez CA, Zhang LF, Garcia-Pastor L, Chavez-Arroyo A, Lokken KL, Tsolis RM, Winter SE, Bäumler AJ. Energy Taxis toward Host-Derived Nitrate Supports a Salmonella Pathogenicity Island 1-Independent Mechanism of Invasion. mBio. 2016;7(4). doi:https://doi.org/10.1128/mBio.00960-16.
- Lim CH, Voedisch S, Wahl B, Rouf SF, Geffers R, Rhen M, Pabst O. Independent bottlenecks characterize colonization of systemic compartments and gut lymphoid tissue by Salmonella. PLoS Pathog. 2014;10(7):e1004270. doi:https://doi.org/10.1371/journal.ppat.1004270.
- Richards AF, Doering JE, Lozito SA, Varrone JJ, Willsey GG, Pauly M, Whaley K, Zeitlin L, Mantis NJ. Inhibition of invasive Salmonella by orally administered IgA and IgG monoclonal antibodies. PLoS Negl Trop Dis. 2020;14(3):e0007803. doi:https://doi.org/10.1371/journal.pntd.0007803.
- Richards AF, Baranova DE, Pizzuto MS, Jaconi S, Willsey GG, Torres-Velez FJ, Doering JE, Benigni F, Mantis NJ. Recombinant human secretory iga induces Salmonella typhimurium agglutination and limits bacterial invasion into gut-associated lymphoid tissues. ACS Infect Dis. 2021;7(5):1221–35. doi:https://doi.org/10.1021/acsinfecdis.0c00842.
- Forbes SJ, Eschmann M, Mantis NJ. Inhibition of Salmonella enterica serovar typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin a antibody. Infect Immun. 2008;76(9):4137–44. doi:https://doi.org/10.1128/IAI.00416-08.
- Forbes SJ, Martinelli D, Hsieh C, Ault JG, Marko M, Mannella CA, Mantis NJ. Association of a protective monoclonal IgA with the O antigen of Salmonella enterica serovar Typhimurium impacts type 3 secretion and outer membrane integrity. Infect Immun. 2012;80(7):2454–63. doi:https://doi.org/10.1128/IAI.00018-12.
- Amarasinghe JJ, D’Hondt RE, Waters CM, Mantis NJ. Exposure of Salmonella enterica Serovar typhimurium to a protective monoclonal IgA triggers exopolysaccharide production via a diguanylate cyclase-dependent pathway. Infect Immun. 2013;81:653–64. doi:https://doi.org/10.1128/IAI.00813-12.
- Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, Neutra MR. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun. 1992;60:1786–92. doi:https://doi.org/10.1128/iai.60.5.1786-1792.1992.
- Michetti P, Porta N, Mahan MJ, Slauch JM, Mekalanos JJ, Blum AL, Kraehenbuhl J-P, Neutra MR. Monoclonal immunoglobulin A prevents adherence and invasion of polarized epithelial cell monolayers by Salmonella typhimurium. Gastroenterology. 1994;107(4):915–23. doi:https://doi.org/10.1016/0016-5085(94)90214-3.
- Virdi V, Juarez P, Boudolf V, Depicker A. Recombinant IgA production for mucosal passive immunization, advancing beyond the hurdles. Cell Mol Life Sci. 2016;73(3):535–45. doi:https://doi.org/10.1007/s00018-015-2074-0.
- Khanal O, Lenhoff AM. Developments and opportunities in continuous biopharmaceutical manufacturing. mAbs. 2021;13:1903664. doi:https://doi.org/10.1080/19420862.2021.1903664.
- Nakanishi K, Matsuda M, Ida R, Hosokawa N, Kurohane K, Niwa Y, Kobayashi H, Imai Y. Lettuce-derived secretory IgA specifically neutralizes the Shiga toxin 1 activity. Planta. 2019;250(4):1255–64. doi:https://doi.org/10.1007/s00425-019-03215-1.
- Stoger E, Fischer R, Moloney M, Ma JK. Plant molecular pharming for the treatment of chronic and infectious diseases. Annu Rev Plant Biol. 2014;65(1):743–68. doi:https://doi.org/10.1146/annurev-arplant-050213-035850.
- Jester B, Zhao H, Gewe M, Adame T, Perruzza L, Bolick D, Agosti, J, Khuong, N, Kuestner, R, Gamble C, Cruickshank K, Ferrara J, Lim R, Paddock T, Brady C, Ertel S, Zhang M, Tasch M, Saveria T, Doughty D, Marshall J, et al. Expression and manufacturing of protein therapeutics in spirulina. bioRxiv 2021:2021.01.25.427910.
- Baranova DE, Chen L, Destrempes M, Meade H, Mantis NJ. Passive immunity to vibrio cholerae O1 afforded by a human monoclonal IgA1 antibody expressed in milk. Pathogens and Immunity. 2020;5(1):89–116. doi:https://doi.org/10.20411/pai.v5i1.370.
- Yu X, Pollock D, Duval M, Lewis C, Joseph K, Meade H, Stoger E, Fischer R, Moloney M. Neutralization of HIV by milk expressed antibody. J Acquir Immune Defic Syndr. 2013;62(1):10–16. doi:https://doi.org/10.1097/QAI.0b013e318271c450.
- Bioley G, Monnerat J, Lotscher M, Vonarburg C, Zuercher A, Corthesy B. Plasma-derived polyreactive secretory-like IgA and IgM opsonizing Salmonella enterica typhimurium reduces invasion and gut tissue inflammation through agglutination. Front Immunol. 2017;8:1043. doi:https://doi.org/10.3389/fimmu.2017.01043.
- Lombana TN, Rajan S, Zorn JA, Mandikian D, Chen EC, Estevez A, Yip V, Bravo DD, Phung W, Farahi F. Production, characterization, and in vivo half-life extension of polymeric IgA molecules in mice. MAbs. 2019;11(6):1122–38. doi:https://doi.org/10.1080/19420862.2019.1622940.
- Muscariello L, De Siena B, Marasco R. Lactobacillus cell surface proteins involved in interaction with mucus and extracellular matrix components. Curr Microbiol. 2020;77(12):3831–41. doi:https://doi.org/10.1007/s00284-020-02243-5.
- Wang YY, Schroeder HA, Nunn KL, Woods K, Anderson DJ, Lai SK, Cone RA. Diffusion of immunoglobulin g in shed vaginal epithelial cells and in cell-free regions of human cervicovaginal mucus. PLoS One. 2016;11:e0158338. doi:https://doi.org/10.1371/journal.pone.0158338.
- Shrestha B, Schaefer A, Chavez EC, Kopp AJ, Jacobs TM, Moench TR, Lai SK. Engineering tetravalent IgGs with enhanced agglutination potencies for trapping vigorously motile sperm in mucin matrix. Acta Biomater. 2020;117:226–34. doi:https://doi.org/10.1016/j.actbio.2020.09.020.